PolyNovo: Presentation, CEO Sessions

Company Presentations

by Carolyn Herbert

PolyNovo's brief is to make regenerative medicine devices and products based on a safe, polyurethane, biodegradable polymer. We listed on the ASX at 29 cents and we have a market cap of $160 million. 
 
The products we are developing are based on a product called NovoSorb and NovoSorb was developed by the CSIRO. and we can make that out into a range of different products. We don't have any biological agents in our product at all compared to the products that are on the market, which are sourced from animal or cadaver skin.
 
We have an excellent bio-compatibility profile and safety profile for our products. Our BTM (Biodegradable Temporising Matrix) is a wound dressing intended for treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal. 

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.